The prevalence and features of the polycystic ovary syndrome in an unselected population

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 6, 2004, Pages 2745-2749

  Azziz, Ricardo ^a,b,d   Woods, Keslie S ^a   Reyna, Rosario ^a   Key, Timothy J ^a   Knochenhauer, Eric S ^a   Yildiz, Bulent O ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c HACETTEPE UNIVERSITY   (Turkey)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID 21 MONOOXYGENASE;

ADRENAL HYPERPLASIA; ADULT; ANAMNESIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; EMPLOYMENT; ETHNOLOGY; EVALUATION; FAMILY HISTORY; FEMALE; HIRSUTISM; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPERANDROGENISM; HYPERPROLACTINEMIA; MENOPAUSE; OVARY POLYCYSTIC DISEASE; OVULATION; PHENOTYPE; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REPRODUCTION; SCORING SYSTEM; SCREENING; STATISTICS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALABAMA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIRSUTISM; HUMANS; JOB APPLICATION; MENSTRUATION DISTURBANCES; MIDDLE AGED; PATIENT SELECTION; POLYCYSTIC OVARY SYNDROME; PREMENOPAUSE; PREVALENCE;

EID: 2942642477     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032046     Document Type: Conference Paper

References (27)

1. Hull MG 1987 Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1:235-245
2. Azziz R 2003 The evaluation and management of hirsutism. Obstet Gynecol 101:995-1007
3. Ovalle F, Azziz R 2002 Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 77:1095-1105
4. Wild RA 2002 Long-term health consequences of PCOS. Hum Reprod Update 8:231-241
5. Legro RS 2003 Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 24:302-312
6. Hardiman P, Pillay OS, Atiomo W 2003 Polycystic ovary syndrome and endometrial carcinoma. Lancet 361:1810-1812
7. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome. In: Dunaif A GJ, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 377-384
8. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082
9. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI 1999 A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011
10. Michelmore KF, Balen AH, Dunger DB, Vessey MP 1999 Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 51:779-786
11. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
12. Ives DG, Traven ND, Kuller LH, Schulz R 1994 Selection bias and nonresponse to health promotion in older adults. Epidemiology 5:456-461
13. Scholle SH, Peele PB, Kelleher KJ, Frank E, Jansen-McWilliams L, Kupfer D 2000 Effect of different recruitment sources on the composition of a bipolar disorder case registry. Soc Psychiatry Psychiatr Epidemiol 35:220-227
14. King AC, Harris RB, Haskell WL 1994 Effect of recruitment strategy on types of subjects entered into a primary prevention clinical trial. Ann Epidemiol 4:312-320
15. 14a. Hatch R, Rosenfield RL, Kim MH, Tredway D 1981 Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140:815-830
16. Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR 1999 Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 72:915-925
17. Boots LR, Potter S, Potter D, Azziz R 1998 Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability. Fertil Steril 69:286-292
18. Azziz R, Bradley Jr EL, Potter HD, Parker Jr CR, Boots LR 1995 Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women. Am J Obstet Gynecol 172: 1251-1256
19. Azziz R, Bradley Jr EL, Potter HD, Boots LR 1995 Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. J Clin Endocrinol Metab 80:400-405
20. Solomon CG, Hu FB, Dunaif A, Rich-Edwards J, Willett WC, Hunter DJ, Colditz GA, Speizer FE, Manson JE 2001 Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 286:2421-2426
21. Farah L, Lazenby AJ, Boots LR, Azziz R 1999 Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. J Reprod Med 44: 870-874
22. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA 1992 Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 167:1807-1812
23. Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE 2002 Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol (Oxf) 57:343-350
24. Flegal KM, Carroll MD, Ogden CL, Johnson CL 2002 Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-1727
25. Malcolm CE, Cumming DC 2003 Does anovulation exist in eumenorrheic women? Obstet Gynecol 102:317-318
26. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
27. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 19:41-47